Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 3,737,500 shares of its Class A common stock, which included 487,500 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a price to the public of $31.00 per share. The gross proceeds to Reata from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $115.9 million.
Four Seasons Resort and Club Dallas at Las Colinas, Texas’ premier resort and golf destination, announces the inaugural Four Seasons Golf and Sports Club Half Marathon, set for November 18, 2017. The event is a member of the Resort Races Collection, a group of exclusive destination race experiences hosted and produced in partnership with the most iconic and luxurious hotels in world.
Our mission is to build the Armstrong family of companies into the industry’s dominating global supplier of moving, relocation, and logistics services.